Department of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
Department of Infection and Host Defense, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
mSphere. 2020 Jan 15;5(1):e00770-19. doi: 10.1128/mSphere.00770-19.
The pathogenic fungus contains galactomannans localized on the surface layer of its cell walls, which are involved in various biological processes. Galactomannans comprise α-(1→2)-/α-(1→6)-mannan and β-(1→5)-/β-(1→6)-galactofuranosyl chains. We previously revealed that GfsA is a β-galactofuranoside β-(1→5)-galactofuranosyltransferase involved in the biosynthesis of β-(1→5)-galactofuranosyl chains. In this study, we clarified the biosynthesis of β-(1→5)-galactofuranosyl chains in Two paralogs exist within : GfsB and GfsC. We show that GfsB and GfsC, in addition to GfsA, are β-galactofuranoside β-(1→5)-galactofuranosyltransferases by biochemical and genetic analyses. GfsA, GfsB, and GfsC can synthesize β-(1→5)-galactofuranosyl oligomers at up to lengths of 7, 3, and 5 galactofuranoses within an established highly efficient assay of galactofuranosyltransferase activity. Structural analyses of galactomannans extracted from Δ, Δ, Δ, and Δ strains revealed that GfsA and GfsC synthesized all β-(1→5)-galactofuranosyl residues of fungal-type and -mannose-type galactomannans and that GfsB exhibited limited function in The loss of β-(1→5)-galactofuranosyl residues decreased the hyphal growth rate and conidium formation ability and increased the abnormal hyphal branching structure and cell surface hydrophobicity, but this loss is dispensable for sensitivity to antifungal agents and virulence toward immunocompromised mice. β-(1→5)-Galactofuranosyl residues are widely distributed in the subphylum Pezizomycotina of the phylum Ascomycota. Pezizomycotina includes many plant and animal pathogens. Although the structure of β-(1→5)-galactofuranosyl residues of galactomannans in filamentous fungi was discovered long ago, it remains unclear which enzyme is responsible for biosynthesis of this glycan. Fungal cell wall formation processes are complicated, and information concerning glycosyltransferases is essential for understanding them. In this study, we showed that GfsA and GfsC are responsible for the biosynthesis of all β-(1→5)-galactofuranosyl residues of fungal-type and -mannose-type galactomannans. The data presented here indicate that β-(1→5)-galactofuranosyl residues are involved in cell growth, conidiation, polarity, and cell surface hydrophobicity. Our new understanding of β-(1→5)-galactofuranosyl residue biosynthesis provides important novel insights into the formation of the complex cell wall structure and the virulence of the members of the subphylum Pezizomycotina.
致病真菌含有定位于细胞壁表面层的半乳甘露聚糖,这些半乳甘露聚糖参与各种生物过程。半乳甘露聚糖由α-(1→2)-/α-(1→6)-甘露聚糖和β-(1→5)-/β-(1→6)-半乳糖呋喃糖基链组成。我们之前揭示了 GfsA 是一种参与β-(1→5)-半乳糖呋喃糖基链生物合成的β-半乳糖呋喃糖苷β-(1→5)-半乳糖呋喃糖基转移酶。在这项研究中,我们阐明了β-(1→5)-半乳糖呋喃糖基链在两种同工酶中的生物合成:GfsB 和 GfsC。我们通过生化和遗传分析表明,GfsB 和 GfsC 除了 GfsA 之外,还是β-半乳糖呋喃糖苷β-(1→5)-半乳糖呋喃糖基转移酶。GfsA、GfsB 和 GfsC 可以在已建立的高效半乳糖呋喃糖基转移酶活性测定中合成长达 7、3 和 5 个半乳糖呋喃糖的β-(1→5)-半乳糖呋喃糖寡聚物。从Δ、Δ、Δ和Δ菌株中提取的半乳甘露聚糖的结构分析表明,GfsA 和 GfsC 合成了真菌型和甘露糖型半乳甘露聚糖的所有β-(1→5)-半乳糖呋喃糖残基,而 GfsB 在真菌型和甘露糖型半乳甘露聚糖中表现出有限的功能。β-(1→5)-半乳糖呋喃糖残基的缺失降低了菌丝生长速率和分生孢子形成能力,增加了异常菌丝分支结构和细胞表面疏水性,但这对于对抗真菌药物的敏感性和对免疫功能低下小鼠的毒力是可有可无的。β-(1→5)-半乳糖呋喃糖残基广泛分布于子囊菌门子囊菌亚门下。子囊菌亚门包括许多植物和动物病原体。尽管丝状真菌半乳甘露聚糖中β-(1→5)-半乳糖呋喃糖残基的结构很久以前就被发现,但负责该聚糖生物合成的酶仍不清楚。真菌细胞壁的形成过程很复杂,了解糖基转移酶的信息对于理解这些过程至关重要。在这项研究中,我们表明 GfsA 和 GfsC 负责真菌型和甘露糖型半乳甘露聚糖中所有β-(1→5)-半乳糖呋喃糖残基的生物合成。这里呈现的数据表明,β-(1→5)-半乳糖呋喃糖残基参与细胞生长、分生孢子形成、极性和细胞表面疏水性。我们对半乳糖呋喃糖残基生物合成的新认识为复杂细胞壁结构的形成和子囊菌亚门成员的毒力提供了重要的新见解。